BOSTON SCIENTIFIC CORPORATION AXIOS STENT AND ELECTROCAUTERY ENHANCED DELIVERY SYSTEM; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE
|
Back to Search Results |
|
Model Number M00553550 |
Device Problems
Premature Activation (1484); Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/14/2023 |
Event Type
malfunction
|
Event Description
|
It was reported to boston scientific corporation that an axios stent and electrocautery enhanced delivery system was to be implanted transduodenal to the pancreas to treat a walled off pancreatic necrosis (wopn) during a drainage procedure performed on (b)(6), 2023.During the procedure, the second flange prematurely deployed outside the scope.The stent was deployed in the correct location, and the abscess cavity was drained.The procedure was completed using the original stent.There were no patient complications as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
|
|
Manufacturer Narrative
|
Block h6: imdrf device code a150103 captures the reportable event of stent prematurely deployed.
|
|
Manufacturer Narrative
|
Block h6: imdrf device code a150103 captures the reportable event of stent prematurely deployed.Block h10: an axios electrocautery enhanced delivery system was received for analysis; the stent was not returned.Visual examination of the returned device found the control hub separated/detached from the handle and the inner sheath kinked.No other problems were noted to the delivery system.The observed failures of control hub separated/detached from the handle and inner sheath kinked were likely due to factors encountered during the procedure.It may be that lesion characteristics, handling of the device and the technique used by the physician (force applied), limited the performance of the device and contributed to the observed failures.The reported event of stent premature deployment cannot be confirmed as this occurred during the procedure, and it is not possible to replicate in the laboratory of analysis.Based on the available information, there is not enough information to confirm the reported event of stent premature deployment; therefore, a review and analysis of all available information indicated the most probable cause is no problem detected.A labeling review was performed and, from the information available, this device was used per the instructions for use (ifu) / product label.
|
|
Event Description
|
It was reported to boston scientific corporation that an axios stent and electrocautery enhanced delivery system was to be implanted transduodenal to the pancreas to treat a walled off pancreatic necrosis (wopn) during a drainage procedure performed on (b)(6) 2023.During the procedure, the second flange prematurely deployed outside the scope.The stent was deployed in the correct location, and the abscess cavity was drained.The procedure was completed using the original stent.There were no patient complications as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
|
|
Search Alerts/Recalls
|
|
|